0001293310 false 0001293310 2023-09-08 2023-09-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares




Washington, D.C. 20549








Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): September 8, 2023



Humanigen, Inc.
(Exact name of registrant as specified in its charter)



(State or other Jurisdiction of



(Commission File No.)


(IRS Employer Identification No.)


830 Morris Turnpike, 4th Floor

Short Hills, New Jersey 07078
(Address of principal executive offices and zip code)

(973) 200-3010
(Registrant's telephone number, including area code)


(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Securities registered pursuant to Section 12(b) of the Act:
  Title of each class



Name of each exchange on which


  Common Stock HGEN The Nasdaq Stock Market LLC
  Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
  Emerging growth company ¨
  If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On September 8, 2023, Edward Jordan informed Humanigen, Inc. (the “Company”) of his resignation from his position as Chief Commercial Officer of the Company, effective September 14, 2023.


Item 9.01. Financial Statements and Exhibits.


(d)       Exhibits






104   Cover Page Interactive Data File (embedded within Inline XBRL document).






Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



Dated: September 14, 2023 By:   /s/ Cameron Durrant
  Name: Cameron Durrant
  Title: Chairman of the Board and Chief Executive Officer







Sep. 08, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 08, 2023
Entity File Number 001-35798
Entity Registrant Name Humanigen, Inc.
Entity Central Index Key 0001293310
Entity Tax Identification Number 77-0557236
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 830 Morris Turnpike
Entity Address, Address Line Two 4th Floor
Entity Address, City or Town Short Hills
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07078
City Area Code 973
Local Phone Number 200-3010
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol HGEN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

Humanigen (NASDAQ:HGEN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Humanigen Charts.
Humanigen (NASDAQ:HGEN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Humanigen Charts.